Thus, in these patients, special attention should be paid to the development of pulmonary fibrosis as a possible sequel to infection by the SARS-CoV-2 virus; KL-6 and YKL-40 are useful tools in this follow-up. The gene discussed is CHI3L1; the disease is pulmonary fibrosis.